Oral microemulsion cyclosporin to reduce steroids rapidly in chronic active ulcerative colitis

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 8, 1999, Pages 905-908

  Actis, Giovanni C ^a   Volpes, Riccardo ^a   Rizzetto, Mario ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Corticosteroids; Cyclosporin; Ulcerative colitis

Indexed keywords

CYCLOSPORIN A; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; DRUG ABSORPTION; FEMALE; HUMAN; MALE; MICROEMULSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0032772679     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199908000-00017     Document Type: Article

References (13)

1. 1 Lichtiger S, Present DH. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990; 336:16-19.
2. 2 Actis GC, Ottobrelli A, Pera A, Barletti C, Ponti V, Pinna-Pintor M, Verme G. Continuously infused cyclosporin at low dose to avoid emergency colectomy in ulcerative colitis without high-dose steroids. J Clin Gastroenterol 1993; 17:10-13.
3. 3 Actis GC, Ottobrelli A, Lagget M, Pera A, Pinna-Pintor M, Verme G. Intravenous cyclosporin for refractory ulcerative colitis. A phase 2 study to reduce dose and toxicity [Abstract]. Gastroenterology 1994; 106(suppl 4):A642.
4. 4 Actis GC, Lagget M, Marzano A, Ottobrelli A, Rizzetto M. Pilot trial of microemulsion cyclosporin capsules (NEORAL) for severe steroid-refractory ulcerative colitis [Abstract]. Gastroenterology 1997; 112(suppl 4):A919.
5. 5 Actis GC, Aimo G, Priolo G, Moscato D, Rizzetto M, Pagni R. Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft-gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflammatory Bowel Dis 1998;4:276-279.
6. 6 Rachmilewitz D. Coated mesalazine versus sulphasalazine in treatment of active ulcerative colitis: a randomized trial. BMJ 1989; 298:82-86.
7. 7 Segoloni GP, Messina M, Squiccimarro G. A diagnostic path in cyclosporin nephrotoxicity. In: Biotechnology in Renal Replacement Therapy. Bonomini V, Scolari MP, Stefoni S, Vangelista A (editors). Basel, Switzerland: Karger, 1989. pp. 94-98.
8. 8 Actis GC, Pinna-Pintor M, Rizzetto M. Azathioprine to maintain the response of acute ulcerative colitis to cyclosporin [Abstract]. Gastroenterology 1998; 114:G3760.
9. 9 Sternthal M, George J, Kornbluth A, Lichtiger S, Present DH. Toxicity associated with the use of cyclosporin in patients with inflammatory bowel disease [Abstract]. Gastroenterology 1996; 110:A1019.
10. 10 Yoon C, Kornbluth A, George J, Sternthal M, Lichtiger S, Marion J, Present DH. Is cyclosporine as effective in chronic ulcerative colitis as in severe ulcerative colitis? [Abstract]. Gastroenterology 1998; 114:G4586.
11. 11 Noble S, Markham A. Cyclosporin: a review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion formulation (NEORAL). Drugs 1995; 50:924-941.
12. 12 Lichtiger S, Present DH, Kornbluth A, Gelemt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330:1841-1845.
13. 13 Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998; 115:813-821.